Manipulating the PANoptosome: baseless hype or a newfound hope for human immunity?

The human immune system uses many tactics to protect itself from harm, attempting to restore homeostatic conditions. Of these tactics, the primary defense mechanism which is activated is innate immunity. Innate immunity employs phagocytic cells which contain Pattern Recognition Receptors (PRRs) on their surface to promote attachment to certain molecules on pathogens and/or generally damaged/injured cells, which contain Pattern-Associated Molecular Patterns (PAMPs) and Damage/Danger-Associated Molecular Patterns (DAMPs), respectively. DAMPs and PAMPs associate with PRRs in host cells. The interaction between innate immune cells and pathogenic molecular patterns triggers programmed cell death (PCD) pathways; the three main ones being pyroptosis, apoptosis, and necroptosis. Historically, the three were thought to operate autonomously, with no intersection between any, but emerging research has brought a new concept into the limelight: PANoptosis. PANoptosis is now recognized as a distinct, innate immune-regulated inflammatory cell death pathway orchestrated by the PANoptosome, a multiprotein complex that integrates molecular components from pyroptosis, apoptosis, and necroptosis, yet functions independently of them. This integrated pathway plays a crucial role in eliminating infected or damaged cells and modulating immune responses. PANoptosis must be tightly regulated at all times, as any abnormality may increase the chances of a multitude of chronic, severe, and potentially terminal illnesses. Developing a better understanding of PANoptosis offers a promising set of possibilities within immunology research and medicine. By elucidating the relationship between the PCD pathways and how they come together to form a PANoptosome, better targets for treatment can be isolated and integrated into new innovative treatments for a wide range of ailments. This review addresses the mechanisms surrounding PANoptosis and its possible implications for the future of medicine, carrying the potential to bridge the gap of knowledge that exists surrounding complex immunological illnesses and also identifying new markers and significant factors contributing to a treatment/cure.